首页>
外国专利>
CYTOTROPIC HETEROGENEOUS MOLECULAR LIPIDS (LMHC), PREPARATION METHOD, AND METHODS FOR TREATMENT OF PATIENTS CARRYING MULTIPLE CANCERS
CYTOTROPIC HETEROGENEOUS MOLECULAR LIPIDS (LMHC), PREPARATION METHOD, AND METHODS FOR TREATMENT OF PATIENTS CARRYING MULTIPLE CANCERS
展开▼
机译:细胞营养异质性脂质(LMHC),制备方法和治疗携带多种癌症的患者的方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
Cytotropic Heterogeneous Molecular Lipids (CHML) are used to treat patients with multiple cancers. Numerous studies have been conducted in cellular, animal, pre-clinical and clinical trials. Results showed that CHML, as a biological molecular missile, can easily penetrate through the target cancerous cells to perform programmed cancer cell death (cancer apoptosis). Furthermore, CHML has produced anti-cancer angiogenesis and induced immune function increase. CHML was used to treat 592 patients with cancers in clinical trials. Results confirmed the following advantages of CHML treatment: non-toxicity, high response rate, high quality of life, and high survival rate for these patients. The protocols include local injection, arterial drip and intravenous drip to treat cancers of liver, lung, skin, breast, brain glioma, colon and rectum, stomach, head and neck, leukemia, malignant lymphoma, sarcoma, malignant melanoma, myeloma, and metastasis cancers, etc.
展开▼